TAIWAN | TFDA submissions

October 3, 2022

Have a look at this infographic that Extedo® and Asphalion have prepared with the summary updates in terms of publishing and eSubmission at a regional level. On this occasion, we are focusing on Taiwan!

As of January 1st, 2020, the use of the eCTD format is mandatory for NDA submissions and voluntary for all other submission types for pharmaceutical, biologic and radiopharmaceutical drugs for human use. At Asphalion we can guide you with the transition to eCTD to be filed for each submission.

ASPHALION and our partner Extedo® can offer you a wide range in Regulatory Services and Solutions in Taiwan, by giving you support in a variety of activities.

You can dowload the document here:

TAIWAN TFDA Infographic

Search News & Events

  • Filter by category

Share

Related news and events

RBDCOV | 14-months follow-up meeting

The second face-to-face RBDCOV meeting is taking place today at Palau Macaya in Barcelona! Our expert, Chris Mann, is attending the meeting in person. After

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting